Abstract
The neuronal PAS domain 3 (NPAS3) gene encodes a neuronal transcription factor that is implicated in psychiatric disorders by the identification of a human chromosomal translocation associated with schizophrenia and a mouse knockout model with behavioural and hippocampal neurogenesis defects. To determine its contribution to the risk of psychiatric illness in the general population, we genotyped 70 single-nucleotide polymorphisms across the NPAS3 gene in 368 individuals with bipolar disorder, 386 individuals with schizophrenia and 455 controls. Modestly significant single-marker and global and individual haplotypes were identified in four discrete regions of the gene. The presence of both risk and protective haplotypes at each of these four regions indicated locus and allelic heterogeneity within NPAS3 and suggested a model whereby interactions between variants across the gene might contribute to susceptibility to illness. This was supported by predicting the most likely haplotype for each individual at each associated region and then calculating an NPAS3-mediated ‘net genetic load’ value. This value differed significantly from controls for both bipolar disorder (P=0.0000010) and schizophrenia (P=0.0000012). Logistic regression analysis also confirmed the combinatorial action of the four associated regions on disease risk. In addition, sensitivity/specificity plots showed that the extremes of the genetic loading distribution possess the greatest predictive power—a feature suggesting multiplicative allele interaction. These data add to recent evidence that the combinatorial analysis of a number of relatively small effect size haplotypes may have significant power to predict an individual's risk of a complex genetic disorder such as psychiatric illness.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Pritchard JK . Are rare variants responsible for susceptibility to complex diseases? Am J Hum Genet 2001; 69: 124–137.
Pritchard JK, Cox NJ . The allelic architecture of human disease genes: common disease–common variant…or not? Hum Mol Genet 2002; 11: 2417–2423.
Yang Q, Khoury MJ, Friedman J, Little J, Flanders WD . How many genes underlie the occurrence of common complex diseases in the population? Int J Epidemiol 2005; 34: 1129–1137.
Glazier AM, Nadeau JH, Aitman TJ . Finding genes that underlie complex traits. Science 2002; 298: 2345–2349.
Reich DE, Lander ES . On the allelic spectrum of human disease. Trends Genet 2001; 17: 502–510.
Pickard BS, Pieper AA, Porteous DJ, Blackwood DH, Muir WJ . The NPAS3 gene—emerging evidence for a role in psychiatric illness. Ann Med 2006; 38: 439–448.
Kamnasaran D, Muir WJ, Ferguson-Smith MA, Cox DW . Disruption of the neuronal PAS3 gene in a family affected with schizophrenia. J Med Genet 2003; 40: 325–332.
Pickard BS, Malloy MP, Porteous DJ, Blackwood DH, Muir WJ . Disruption of a brain transcription factor, NPAS3, is associated with schizophrenia and learning disability. Am J Med Genet B Neuropsychiatr Genet 2005; 136: 26–32.
Brunskill EW, Ehrman LA, Williams MT, Klanke J, Hammer D, Schaefer TL et al. Abnormal neurodevelopment, neurosignaling and behaviour in Npas3-deficient mice. Eur J Neurosci 2005; 22: 1265–1276.
Pieper AA, Wu X, Han TW, Estill SJ, Dang Q, Wu LC et al. The neuronal PAS domain protein 3 transcription factor controls FGF-mediated adult hippocampal neurogenesis in mice. Proc Natl Acad Sci USA 2005; 102: 14052–14057.
Erbel-Sieler C, Dudley C, Zhou Y, Wu X, Estill SJ, Han T et al. Behavioral and regulatory abnormalities in mice deficient in the NPAS1 and NPAS3 transcription factors. Proc Natl Acad Sci USA 2004; 101: 13648–13653.
Reif A, Schmitt A, Fritzen S, Lesch KP . Neurogenesis and schizophrenia: dividing neurons in a divided mind? Eur Arch Psychiatry Clin Neurosci 2007; 257: 290–299.
Sahay A, Hen R . Adult hippocampal neurogenesis in depression. Nat Neurosci 2007; 10: 1110–1115.
Brunskill EW, Witte DP, Shreiner AB, Potter SS . Characterization of npas3, a novel basic helix–loop–helix PAS gene expressed in the developing mouse nervous system. Mech Dev 1999; 88: 237–241.
Liu QR, Drgon T, Johnson C, Walther D, Hess J, Uhl GR . Addiction molecular genetics: 639,401 SNP whole genome association identifies many “cell adhesion” genes. Am J Med Genet B Neuropsychiatr Genet 2006; 141: 918–925.
Blouin JL, Dombroski BA, Nath SK, Lasseter VK, Wolyniec PS, Nestadt G et al. Schizophrenia susceptibility loci on chromosomes 13q32 and 8p21. Nat Genet 1998; 20: 70–73.
Arinami T, Ohtsuki T, Ishiguro H, Ujike H, Tanaka Y, Morita Y et al. Genomewide high-density SNP linkage analysis of 236 Japanese families supports the existence of schizophrenia susceptibility loci on chromosomes 1p, 14q, and 20p. Am J Hum Genet 2005; 77: 937–944.
Marcheco-Teruel B, Flint TJ, Wikman FP, Torralbas M, Gonzalez L, Blanco L et al. A genome-wide linkage search for bipolar disorder susceptibility loci in a large and complex pedigree from the eastern part of Cuba. Am J Med Genet B Neuropsychiatr Genet 2006; 141: 833–843.
International HapMap Consortium. A haplotype map of the human genome. Nature 2005; 437: 1299–1320.
Barrett JC, Fry B, Maller J, Daly MJ . Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005; 21: 263–265.
Bejerano G, Pheasant M, Makunin I, Stephen S, Kent WJ, Mattick JS et al. Ultraconserved elements in the human genome. Science 2004; 304: 1321–1325.
Pollard KS, Salama SR, Lambert N, Lambot MA, Coppens S, Pedersen JS et al. An RNA gene expressed during cortical development evolved rapidly in humans. Nature 2006; 443: 167–172.
Pickard BS, Malloy MP, Christoforou A, Thomson PA, Evans KL, Morris SW et al. Cytogenetic and genetic evidence supports a role for the kainate-type glutamate receptor gene, GRIK4, in schizophrenia and bipolar disorder. Mol Psychiatry 2006; 11: 847–857.
Thomson PA, Christoforou A, Morris SW, Adie E, Pickard BS, Porteous DJ et al. Association of neuregulin 1 with schizophrenia and bipolar disorder in a second cohort from the Scottish population. Mol Psychiatry 2007; 12: 94–104.
Thomson PA, Wray NR, Millar JK, Evans KL, Hellard SL, Condie A et al. Association between the TRAX/DISC locus and both bipolar disorder and schizophrenia in the Scottish population. Mol Psychiatry 2005; 10: 657–668, 616.
Christoforou A, Le Hellard S, Thomson PA, Morris SW, Tenesa A, Pickard BS et al. Association analysis of the chromosome 4p15–p16 candidate region for bipolar disorder and schizophrenia. Mol Psychiatry 2007; 12: 1011–1025.
Dudbridge F . Pedigree disequilibrium tests for multilocus haplotypes. Genet Epidemiol 2003; 25: 115–121.
Stephens M, Donnelly P . A comparison of Bayesian methods for haplotype reconstruction from population genotype data. Am J Hum Genet 2003; 73: 1162–1169.
Stephens M, Smith NJ, Donnelly P . A new statistical method for haplotype reconstruction from population data. Am J Hum Genet 2001; 68: 978–989.
Berrettini WH . Genetics of psychiatric disease. Annu Rev Med 2000; 51: 465–479.
Wu X, Gu J, Grossman HB, Amos CI, Etzel C, Huang M et al. Bladder cancer predisposition: a multigenic approach to DNA-repair and cell-cycle-control genes. Am J Hum Genet 2006; 78: 464–479.
Johnson N, Fletcher O, Palles C, Rudd M, Webb E, Sellick G et al. Counting potentially functional variants in BRCA1, BRCA2 and ATM predicts breast cancer susceptibility. Hum Mol Genet 2007; 16: 1051–1057.
Maller J, George S, Purcell S, Fagerness J, Altshuler D, Daly MJ et al. Common variation in three genes, including a noncoding variant in CFH, strongly influences risk of age-related macular degeneration. Nat Genet 2006; 38: 1055–1059.
Baum AE, Akula N, Cabanero M, Cardona I, Corona W, Klemens B et al. A genome-wide association study implicates diacylglycerol kinase eta (DGKH) and several other genes in the etiology of bipolar disorder. Mol Psychiatry 2007; 13: 197–207.
Acknowledgements
This work was supported by a Royal College of Physicians, Edinburgh SIM Research Fellowship (to BP). Additional funding was from a Collaborative Research Agreement with Merck, Sharp and Dohme, Terling's Park, UK. We thank Simon Cooper and Margaret van Beck for their contributions to this paper.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Pickard, B., Christoforou, A., Thomson, P. et al. Interacting haplotypes at the NPAS3 locus alter risk of schizophrenia and bipolar disorder. Mol Psychiatry 14, 874–884 (2009). https://doi.org/10.1038/mp.2008.24
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/mp.2008.24
Keywords
This article is cited by
-
Investigation of genetic loci shared between bipolar disorder and risk-taking propensity: potential implications for pharmacological interventions
Neuropsychopharmacology (2021)
-
Identification of genetic overlap and novel risk loci for attention-deficit/hyperactivity disorder and bipolar disorder
Molecular Psychiatry (2021)
-
Pathogenic variants in E3 ubiquitin ligase RLIM/RNF12 lead to a syndromic X-linked intellectual disability and behavior disorder
Molecular Psychiatry (2019)
-
Genetic pleiotropy between mood disorders, metabolic, and endocrine traits in a multigenerational pedigree
Translational Psychiatry (2018)
-
Associating transcription factors and conserved RNA structures with gene regulation in the human brain
Scientific Reports (2017)